The hsa-let-7e-5p was found to be a tumor suppressor to inhibit the progression of head and neck squamous cell carcinoma by targeting CCR7 expression (Wang et al., 2019) and a potential prognosis marker for rectal carcinoma with liver metastases (Chen et al., 2018). Here, CCR7 is linked to head and neck squamous cell carcinoma.